North America’s medical devices industry saw a drop of 32.99% in deal activity during October 2021, when compared with the last 12-month average, led by Boston Scientific’s $1.75bn acquisition of Baylis MedicalInc, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.


A total of 65 medical devices industry deals worth $4.7bn were announced for the region in October 2021, against the 12-month average of 97 deals.

Of all the deal types, venture financing saw most activity in October 2021 with 46 transactions, representing a 70.8% share for the region.

In second place was M&A with 16 deals, followed by private equity deals with three transactions, respectively capturing a 24.6% and 4.6% share of the overall deal activity for the month.

In terms of value of deals, M&A was the leading category in North America’s medical devices industry with $2.72bn, while venture financing and private equity deals totalled $1.92bn and $20m, respectively.

North America medical devices industry deals in October 2021: Top deals

The top five medical devices deals accounted for 70.3% of the overall value during October 2021.

The combined value of the top five medical devices deals stood at $3.27bn, against the overall value of $4.7bn recorded for the month.

The top five medical devices industry deals of October 2021 tracked by GlobalData were:

1) Boston Scientific $1.75bn acquisition deal with Baylis MedicalInc

2) The $600m venture financing of Hinge Health by Alkeon Capital,Coatue Management,Tiger Global and Whale Rock Capital Management

3) 3D Systems $400m acquisition deal with Volumetric

4) The $304m venture financing of Medable by Blackstone,GSR Ventures,Sapphire Ventures,Tiger Global Management and Western Technology Investment

5) Integer $220m acquisition deal with Oscor